214 related articles for article (PubMed ID: 6106283)
1. [Treatment with dimethylaminoethanol (deanol) in neuroleptic induced tardive dyskinesia].
Kocher R; Hobi V; Linder M; Studer K
Schweiz Arch Neurol Neurochir Psychiatr; 1980; 126(1):103-9. PubMed ID: 6106283
[TBL] [Abstract][Full Text] [Related]
2. [Dimethylaminoethanol in the treatment of neuroleptic-induced tardive dyskinesia].
Lambert PA; Wolff P; de Maximy B; Ghenim A
Ann Med Psychol (Paris); 1978 Apr; 136(4):625-9. PubMed ID: 31832
[No Abstract] [Full Text] [Related]
3. Deanol, lithium and placebo in the treatment of tardive dyskinesia. A double-blind crossover study.
Jus A; Villeneuve A; Gautier J; Jus K; Villeneuve C; Pires P; Villeneuve R
Neuropsychobiology; 1978; 4(3):140-9. PubMed ID: 340975
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic measures in tardive dyskinesia].
Tegeler J; Wöller W
Fortschr Neurol Psychiatr; 1983 Jun; 51(6):203-26. PubMed ID: 6136457
[TBL] [Abstract][Full Text] [Related]
5. Electromyographic assessment of dimethylaminoethanol (deanol) in treatment of tardive dyskinesia.
Lonowski DJ; Sterling FE; King HA
Psychol Rep; 1979 Oct; 45(2):415-9. PubMed ID: 538170
[No Abstract] [Full Text] [Related]
6. Deanol acetamidobenzoate (Deaner) in tardive dyskinesia.
Stafford JR; Fann WE
Dis Nerv Syst; 1977 Dec; 38(12 Pt 2):3-6. PubMed ID: 590063
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of 37 cases of tardive dyskinesia by deanol].
Cai N
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug; 18(4):234-6. PubMed ID: 4075918
[No Abstract] [Full Text] [Related]
8. Double-blind evaluation of deanol in tardive dyskinesia.
Penovich P; Morgan JP; Kerzner B; Karch F; Goldblatt D
JAMA; 1978 May; 239(19):1997-8. PubMed ID: 347112
[TBL] [Abstract][Full Text] [Related]
9. [Deanol in tardive dyskinesia: a double-blind study (author's transl)].
Bockenheimer S; Lucius G
Arch Psychiatr Nervenkr (1970); 1976 Sep; 222(1):69-75. PubMed ID: 791197
[TBL] [Abstract][Full Text] [Related]
10. Double blind controlled trial of deanol in tardive dyskinesia.
George J; Pridmore S; Aldous D
Aust N Z J Psychiatry; 1981 Mar; 15(1):68-71. PubMed ID: 6942835
[TBL] [Abstract][Full Text] [Related]
11. Tardive dyskinesia treated with deanol acetamidobenzoate.
Ray I
Can Med Assoc J; 1977 Jul; 117(2):129. PubMed ID: 872010
[No Abstract] [Full Text] [Related]
12. Ineffectiveness of deanol in tardive dyskinesia: a placebo controlled study.
de Montigny C; Chouinard G; Annable L
Psychopharmacology (Berl); 1979 Nov; 65(3):219-23. PubMed ID: 117492
[TBL] [Abstract][Full Text] [Related]
13. Deanol in the treatment of tardive dyskinesia.
Simpson GM; Voitashevsky A; Young MA; Lee JH
Psychopharmacology (Berl); 1977 May; 52(3):257-61. PubMed ID: 406628
[TBL] [Abstract][Full Text] [Related]
14. Deanol acetamidobenzoate treatment in choreiform movement disorders.
Tarsy D; Bralower M
Arch Neurol; 1977 Dec; 34(12):756-8. PubMed ID: 145212
[TBL] [Abstract][Full Text] [Related]
15. [Beta blockade with celiprolol in tardive dyskinesia patients treated with neuroleptics].
Hebenstreit GF; Hoffmann H; Hoffmann W; Pittner H
Wien Klin Wochenschr; 1986 Jun; 98(12):388-92. PubMed ID: 2874663
[TBL] [Abstract][Full Text] [Related]
16. Efficacies of agents related to GABA, dopamine, and acetylcholine in the treatment of tardive dyskinesia [proceedings].
Chien C; Jung K; Ross-Townsend A
Psychopharmacol Bull; 1978 Apr; 14(2):20-2. PubMed ID: 26102
[No Abstract] [Full Text] [Related]
17. Cholinergic influences in tardive dyskinesia.
Tamminga CA; Smith RC; Ericksen SE; Chang S; Davis JM
Am J Psychiatry; 1977 Jul; 134(7):769-74. PubMed ID: 869054
[TBL] [Abstract][Full Text] [Related]
18. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
Bai YM; Yu SC; Lin CC
J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
[TBL] [Abstract][Full Text] [Related]
19. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
Silver H; Geraisy N; Schwartz M
J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
[TBL] [Abstract][Full Text] [Related]
20. Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study.
Miyaoka T; Furuya M; Yasuda H; Hayashida M; Nishida A; Inagaki T; Horiguchi J
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):761-4. PubMed ID: 18201810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
